Gladstone Capital Management LLP Amarin Corp Plcuk Transaction History

Gladstone Capital Management LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$4.78 - $8.26 $1.94 Million - $3.35 Million	-405,751 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$4.0 - $21.53 $823,004 - $4.43 Million	205,751 Added 102.88%	405,751 $1.62 Million
Q4 2019 Feb 07, 2020	BUY	$13.94 - $24.12 $2.79 Million - $4.82 Million	200,000 New	200,000 $4.29 Million
Q2 2019 Aug 08, 2019	SELL	$16.27 - $20.51 $3.78 Million - $4.76 Million	-232,085 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $1.08 Million - $1.91 Million	-85,344 Reduced 26.89%	232,085 $4.82 Million
Q4 2018 Feb 08, 2019	BUY	$12.41 - $22.98 $3.94 Million - $7.29 Million	317,429 New	317,429 $4.32 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Gladstone Capital Management LLP, based on Form 13F filings with the SEC.

Stay updated on Gladstone Capital Management LLP with notifications on news.